The researchers focused specifically on the IL23R gene, which plays a key role in immune regulation. "The exact causes of chronic inflammatory bowel diseases remain unknown. However, previous ...

Proposed acquisition adds Nimble's lead asset, an investigational oral peptide IL23R inhibitor in preclinical development for psoriasis, and a pipeline of other novel oral peptide assets across ...

The acquisition includes Nimble's investigational lead candidate, an oral peptide IL23R inhibitor currently in preclinical development for psoriasis, and a pipeline of new oral peptide candidates ...